EMBL institutional partnerships are close cooperative affiliations between EMBL and external institutions of comparable standard, vision and international orientation. Working relationships at the institutional level are based on shared institutional goals and scientific synergy or complementarity. The aim is to leverage the EMBL model together with the strengths of the partners, to create an interlinked system of excellent institutions that enhance molecular life science in Europe and the world. Read more about EMBL Partnerships in the FAQ >
Involving institutions on or near EMBL campuses, benefiting from shared infrastructure and equipment.
Implementing EMBL’s research strategy and operational model on the national level in member states.
General, 5 December 2018 New EMBL Partnership in Hungary EMBL has recently formed an inter-institutional collaboration with the Hungarian Centre of Excellence for Molecular Medicine (HCEMM), setting the stage for the ongoing transfer of institutional, research and collaborative expertise between the two organisations. Researchers at HCEMM will also have access to the EMBL Partnership network across Europe and further afield. HCEMM is a newly established non-profit organisation, researching the diagnosis and treatment of cancer, cardiovascular and inflammatory diseases. It will bridge the gap between fundamental and translational research by undertaking projects with relatively rapid clinical applications.
Hinxton, 8 November 2018 Genomes of all known UK species to be sequenced The genetic code of 66,000 UK species will be sequenced by the Wellcome Sanger Institute in a major collaboration with EMBL’s European Bioinformatics Institute (EMBL-EBI) and other partner organisations as part of a global effort to sequence all 1.5 million known species of animal, plant, protozoa and fungi on Earth. The UK project, known as the Darwin Tree of Life Project, launched 1 November alongside the global effort, the Earth BioGenome Project. The Earth BioGenome Project will ultimately create a new foundation for biology to drive solutions for preserving biodiversity and sustaining human societies.
Heidelberg, 1 October 2018 Ageing is visible in the way cells use glucose A research team from EMBL and Heidelberg University has studied the molecular features of ageing in human blood stem cells. The most prominent finding is that the sugar metabolism of stem cells increases with age – a change similar to that observed in cancer cells. This is coupled with a decline in stem cell functionality and in immune defense.Their results, published in Nature Communications on 1st October 2018, serve as an important reference for further studies on the molecular mechanisms of ageing in humans. The paper’s first authors are Marco L. Hennrich, mass spectrometrist at EMBL, Natalie Romanov, predoctoral fellow in bioinformatics at EMBL, and Patrick Horn, cell biologist at Heidelberg University.
Hamburg, 22 November 2017 Hands-on science inspires Hamburg A giant particle accelerator may not be the typical place to hang out on a Saturday night, but on 4 November, thousands of people made their way to DESY (Deutsches Elektronen-Synchrotron), as part of the biennial Hamburg Night of the Sciences. Visitors uncovered the secrets of the three famous X-ray radiation sources PETRA III, FLASH and XFEL, through talks and practical activities. EMBL’s site on the DESY campus surprised and entertained guests with insights into the tiny molecular machines that build the basis of life: proteins.
Hamburg, 14 November 2017 CSSB: A new approach to infectious disease On the DESY campus in Hamburg, the Centre for Structural Systems Biology (CSSB) is ready to make its mark as the new kid on the block and tackle some of the most important questions relating to how infections take hold in our bodies